Skip to main content
. 2006 Jul;50(7):2471–2477. doi: 10.1128/AAC.00138-06

TABLE 1.

Anti-HBV activities of tenofovir and related compounds in HepG2 2.2.15 cells

Compound EC50 (μM)a n
Tenofovir 1.1 ± 0.3 5
Tenofovir DF 0.02 ± 0.01 2
Adefovir 0.8 ± 0.2 3
ADV 0.1 ± 0.01 3
Lamivudine 0.06 ± 0.01 3
a

Mean ± standard deviation from the indicated number of independent experiments (n).